NFKB1 and glioblastoma: A PTV-loaded nanocarrier was developed to trigger the apoptosis of glioblastoma multiforme cells by reducing the mRNA levels of NFKB, IL6, BIRC1, and BIRC5 (Psc et al., 2021).